ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Cancer Control RFA Announcements

March 9, 1979

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004